Study of proteins modulating gliosis in cerebrospinal fluid in neurodegenerative diseases
Not Applicable
- Conditions
- amyotrophic lateral sclerosis (ALS)
- Registration Number
- JPRN-UMIN000030060
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of intrathecal infection Patients with a history of intrathecal drug administration Patients with a history of spine or spinal cord surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantification of gliosis-moderating proteins in CSF from ALS patients using enzyme-linked immunosorbent assay (ELISA)
- Secondary Outcome Measures
Name Time Method